Diametric Capital’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
KCM
Diametric Capital's BEAM Position: Q3 2026 in Review
Diametric Capital opened a new position in Beam Therapeutics (BEAM) in Q3 2026: 13,214 shares worth $323K. The stake represents 0.03% of the portfolio and ranks #462 among its holdings.
264 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Diametric Capital held 13,214 shares of Beam Therapeutics worth $323K as of Q3 2026.
- Beam Therapeutics was a new Diametric Capital position in Q3 2026.
- Beam Therapeutics made up 0.03% of Diametric Capital's portfolio in Q3 2026, its #462 holding.
- 264 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Diametric Capital's 13F filing for Q3 2026, filed 16 Nov 2026.